For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Where next for primary care in New Zealand?
+Opinion
20 MILLION CONSULTS
Where next for primary care in New Zealand?
Friday 20 October 2023, 11:02 AM

For years, New Zealand Doctor Rata Aotearoa has been running commentary articles on the problems faced by primary care as it sits in the shadow of secondary services. I'm browsing through the archives to bring some of those commentaries back to light. This one sees visiting fellow Judith Smith considering what happened with the Primary Health Care Strategy and what the change from a Labour to National Government might hold in 2009. It was published in the 11 February issue 2009 issue - Editor
A change of government and a new year are reasons to pause and reflect on what has gone before, and make resolutions for the next phase.
The Primar
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.